Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 83 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
821 13.2 months Newly diagnosed GBM 4 Chemotherapy
Radiation
University of Texas MD Anderson Cancer Center United States 10/2002
Treatment Details: Patients: This Phase II study included a total of 57 patients - twenty-one newly diagnosed patients with anaplastic astrocytoma and thirty-six newly diagnosed patients with glioblastoma mult
 
822 13.2 months Metastatic rcc 4 Biologic therapy
Immunotherapy
The Norwegian Radium Hospital Norway 6/2005
Treatment Details: Patients: This Phase II/III trial involved a total of 320 patients with progressive metastatic renal cell carcinoma. There were 222 men and 98 women. The ages ranged from 25 to 75. The me
 
823 13.2 months advanced colorectal cancer 5 Chemotherapy
Universidad Autonoma de Madrid Spain 3/2006
Treatment Details: Patients: This Phase II study involved 50 patients (36 men, 14 women, average age 76 years) with metastatic colorectal cancer. While one third of the patients had received adjuvant therapy
 
824 13.2 months Recurrent NSCLC 4 Chemotherapy
Taipei Veterans General Hospital Taiwan Region 3/2006
Treatment Details: Patients: This Phase II study involved 45 patients (28 men, 17 women, average age 65.1 years) with advanced non-small-cell lung cancer. All patients did not respond to platinum-based chemot
 
825 13.2 months Epithelial ovarian cancer, primary fallopian tube cancer, primary peritoneal cancer 5 Chemotherapy
Università Milano-Bicocca Italy 11/2012
Treatment Details: Patients: This phase 3 study involved epithelial ovarian, primary fallopian tube, and primary peritoneal cancer patients previously treated with platinum-based chemotherapy who were divided
 
826 13.2 months Advanced hepatocellular carcinoma 5 Radiation
University of Bologna Italy 4/2014
Treatment Details: Patients: This study involved previously untreated advanced hepatocellular cancer patients who were divided into two separate treatment groups. Group A consisted of 74 patients with an ave
 
827 13.1 months Advanced triple-negative breast cancer 5 Chemotherapy
Université Libre de Bruxelles Belgium 4/2014
Treatment Details: Patients: This phase 2 study involved female advanced triple-negative breast cancer (TNBC) patients who were divided into three separate treatment groups. Group A consisted of 55 patients
 
828 13.1 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Hormone
Massachusetts General Hospital Cancer Center United States 1/2014
Treatment Details: Patients: This phase 3 study involved previously treated, metastatic castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted of
 
829 13.1 months Metastatic melanoma 4 Biologic therapy
Istituto Nazionale Tumori Fondazione Pascale Italy 9/2013
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into separate groups based on the specific genetic mutation of their cancer. Group A consisted of 76 pat
 
830 13.1 months Advanced urothelial cancer 4 Chemotherapy
University of Michigan Comprehensive Cancer Center United States 2/2014
Treatment Details: Patients: This phase 2 study involved 16 advanced urothelial carcinoma patients with a median age of 73.9 years; 81.3% were male. Treatment: Patients were treated with the chemotherapy
 
Page 83 of 187  | Previous Page  | Next Page